https://www.businesswire.com/news/home/20220322005489/en/LiverMultiScan%C2%AE-Detected-Earlier-Stages-of-Treatable-Disease-in-Patients-With-Autoimmune-Hepatitis-to-Allow-Tailored-Treatment
New study with Perspectum’s LiverMultiScan's cT1 measurements found to identify likely disease progression better than blood biomarkers and FibroScan®
Create an account or login to join the discussion